[10] [22] Disease-modifying therapies commonly used in MS include: Injectable therapies : Interferon beta preparations (Avonex, Rebif, Betaseron) and glatiramer acetate (Copaxone) Oral agents : Fingolimod (Gilenya), dimethyl fumarate (Tecfidera), teriflunomide (Aubagio), siponimod (Mayzent), ozanimod (Zeposia), and cladribine (Mavenclad) Infusion therapies : Natalizumab (Tysabri), ocrelizumab (Ocrevus), alemtuzumab (Lemtrada) Subcutaneous injection : Ofatumumab (Kesimpta) No direct drug-drug interactions between tirzepatide and these DMTs have been identified in pharmacological studies
Start your intake How Caffeine Affects Your Digestive System During GLP-1 Therapy Tirzepatide slows gastric emptying, meaning food and liquids move more slowly from your stomach into your intestines
How long will it take for Wegovy to leave your system
A realistic oral titration schedule might look like: Week 1-4: 50 mg daily (equivalent to ~2.5 mg injected weekly) Week 5-8: 100 mg daily (equivalent to ~5 mg injected weekly) Week 9-12: 150 mg daily (equivalent to ~7.5 mg injected weekly) Each dose increase requires a larger absolute dose increment (50 mg, not 2.5 mg), which means each titration step exposes the patient to a larger pharmacokinetic jump
Two sessions a week covering the main muscle groups is a reasonable target to build towards